Apex Healthcare Bhd (KLSE:7090) — Market Cap & Net Worth
Market Cap & Net Worth: Apex Healthcare Bhd (7090)
Apex Healthcare Bhd (KLSE:7090) has a market capitalization of $473.43 Million (RM1.89 Billion) as of July 8, 2026. Listed on the KLSE stock exchange, this Malaysia-based company holds position #12507 globally and #133 in its home market, demonstrating a -1.14% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Apex Healthcare Bhd's stock price RM2.61 by its total outstanding shares 722478546 (722.48 Million). See Apex Healthcare Bhd (7090) capital reinvestment to understand how much of operating cash flow is reinvested back into capital assets.
Apex Healthcare Bhd Market Cap History: 2015 to 2026
Apex Healthcare Bhd's market capitalization history from 2015 to 2026. Data shows growth from $91.48 Million to $473.43 Million (16.95% CAGR).
Apex Healthcare Bhd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Apex Healthcare Bhd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.47x
Apex Healthcare Bhd's market cap is 0.47 times its annual revenue
Latest Price to Earnings (P/E) Ratio
5.85x
Apex Healthcare Bhd's market cap is 5.85 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $91.48 Million | $527.00 Million | $34.00 Million | 0.17x | 2.69x |
| 2016 | $112.50 Million | $581.27 Million | $34.95 Million | 0.19x | 3.22x |
| 2017 | $150.14 Million | $620.26 Million | $44.46 Million | 0.24x | 3.38x |
| 2018 | $213.30 Million | $652.66 Million | $58.58 Million | 0.33x | 3.64x |
| 2019 | $249.21 Million | $688.79 Million | $52.75 Million | 0.36x | 4.72x |
| 2020 | $398.93 Million | $698.73 Million | $56.02 Million | 0.57x | 7.12x |
| 2021 | $308.64 Million | $770.76 Million | $59.42 Million | 0.40x | 5.19x |
| 2022 | $411.70 Million | $877.74 Million | $100.97 Million | 0.47x | 4.08x |
| 2023 | $443.37 Million | $936.17 Million | $397.99 Million | 0.47x | 1.11x |
| 2024 | $448.03 Million | $961.78 Million | $76.54 Million | 0.47x | 5.85x |
Competitor Companies of 7090 by Market Capitalization
Companies near Apex Healthcare Bhd in the global market cap rankings as of July 8, 2026.
Key companies related to Apex Healthcare Bhd by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #266 globally with a market cap of $94.62 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #534 globally with a market cap of $50.53 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #631 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1140 globally with a market cap of $23.03 Billion USD ( AU$32.55 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #266 | McKesson Corporation | NYSE:MCK | $94.62 Billion | $807.33 |
| #534 | Cencora Inc. | NYSE:COR | $50.53 Billion | $304.48 |
| #631 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $239.71 |
| #1140 | Sigma Healthcare Ltd | AU:SIG | $23.03 Billion | AU$2.82 |
Apex Healthcare Bhd Historical Marketcap From 2015 to 2026
Between 2015 and today, Apex Healthcare Bhd's market cap moved from $91.48 Million to $ 473.43 Million, with a yearly change of 16.95%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | RM473.43 Million | -1.14% |
| 2025 | RM478.87 Million | +6.88% |
| 2024 | RM448.03 Million | +1.05% |
| 2023 | RM443.37 Million | +7.69% |
| 2022 | RM411.70 Million | +33.39% |
| 2021 | RM308.64 Million | -22.63% |
| 2020 | RM398.93 Million | +60.08% |
| 2019 | RM249.21 Million | +16.84% |
| 2018 | RM213.30 Million | +42.07% |
| 2017 | RM150.14 Million | +33.46% |
| 2016 | RM112.50 Million | +22.98% |
| 2015 | RM91.48 Million | -- |
End of Day Market Cap According to Different Sources
On Jul 8th, 2026 the market cap of Apex Healthcare Bhd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $473.43 Million USD |
| MoneyControl | $473.43 Million USD |
| MarketWatch | $473.43 Million USD |
| marketcap.company | $473.43 Million USD |
| Reuters | $473.43 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Apex Healthcare Bhd
Apex Healthcare Berhad, an investment holding company, engages in the development, manufacture, marketing, distribution, and wholesale of pharmaceutical and healthcare products in Malaysia, Singapore, and internationally. It operates in three segments: Manufacturing, Distribution, and Corporate. The company offers a range of products, including cough mixture and antihistamine, anti-infective, ant… Read more